About BU CTSI
Established in 2008, the Boston University Clinical and Translational Science Institute (BU CTSI) has emerged as a leader in advancing translational science. Our partner Boston Medical Center Health System (BMCHS), which is comprised of Boston Medical Center, two regional hospitals, 13 community health centers (CHCs) and a health plan, is involved in all aspects of the BU CTSI. The Veterans Administration Boston Health System (VABHS), our collaborator, is an essential contributor to the BU CTSI.
Supported by a Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS) under the National Institutes of Health (NIH), BU CTSI has secured over $113 million in funding to provide essential tools, resources, and services to clinical investigators. This support enhances the impact of discoveries and facilitates the rapid translation of research into improved patient care through collaborative efforts. Guided by a mission to advance translational science and improve health, the BU CTSI focuses on accelerating scientific discoveries that benefit all populations.
Our Vision
The vision of the Boston University Clinical and Translational Science Institute is to cultivate a sustainable ecosystem for an inclusive research community to advance health and health equity through collaborative and innovative scientific knowledge generation, translation, communication and dissemination.
BU CTSI Directors
David M. Center, MD
Founding PI and Gordon & Ruth Snider Professor of Pulmonary Medicine and the Associate Provost for Translational Research at Boston University.
Megan Bair-Merritt, MD, MSCE
Multi-PI and Professor of Pediatrics, and the Chief Scientific Officer and Vice President of Boston Medical Center Health System (BMCHS).
